Filing Details
- Accession Number:
- 0001181431-10-021713
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-15 13:00:00
- Reporting Period:
- 2010-04-13
- Filing Date:
- 2010-04-15
- Accepted Time:
- 2010-04-15 16:03:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1135906 | Combinatorx Inc | CRXX | Pharmaceutical Preparations (2834) | 043514457 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1432004 | T Hartley Richardson | C/O Combinatorx, Incorporated 245 First Street, 3Rd Floor Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-13 | 161,200 | $1.24 | 199,357 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,426,835 | Indirect | By James Richardson & Sons, Limited |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.20 to $1.30, inclusive. The reporting person undertakes to provide to CombinatoRx, Incorporated, any security holder of CombinatoRx, Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- Represents securities held by James Richardson & Sons, Limited. The reporting person may be deemed to have an indirect pecuniary interest in securities held by James Richardson & Sons, Limited. The reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.